September 25, 2021

Volume XI, Number 268

Advertisement

September 24, 2021

Subscribe to Latest Legal News and Analysis

September 23, 2021

Subscribe to Latest Legal News and Analysis

September 22, 2021

Subscribe to Latest Legal News and Analysis

Intellectual Property, Patent, Trademark and Copyright Law News

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

For hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Date Title Organization
24
Sep
The Battle over BLACK IRISH Liqueur Norris McLaughlin P.A.
24
Sep
Beijing Patent Attorney Association Research Shows Chinese Patent Drafting is 1/4 the Price of U.S. Patent Drafting Schwegman, Lundberg & Woessner, P.A.
24
Sep
A Look at AIA § 3(n)(2): Part Two of a Two-Part Series on AIA § 3(n) Effective Filing Date Provisions Finnegan
24
Sep
World Intellectual Property Organization Releases Global Innovation Index 2021 – China Edges Closer to Top 10 Schwegman, Lundberg & Woessner, P.A.
23
Sep
Patent Owner Tip #18 for Surviving an Instituted IPR: Defending Depositions Mintz
23
Sep
Combatting the Rise in False Advertising by White-Label Manufacturers on The Internet K&L Gates
23
Sep
Not on My Watch: Disclosure of Restored Goods’ Source Obviates Consumer Confusion McDermott Will & Emery
23
Sep
De Minimis Defense Doesn’t Protect Minimal Use of Concededly Infringing Material McDermott Will & Emery
23
Sep
Discretion to Authorize Hague Alternative Service on Foreign Defendant—It’s All About Time and Cost McDermott Will & Emery
23
Sep
EXCLUSIVE RIGHTS: Intellectual Property — Blockchain, Cryptocurrency, and IP: What Does the Future Hold? [PODCAST] Mintz
23
Sep
California Passes Legislation Regarding Job Performance Quotas for Large Warehouse Facilities Jackson Lewis P.C.
22
Sep
The Central Committee of the Communist Party of China and the State Council issued the “Guidelines for Building a Powerful Country with Intellectual Property Rights (2021-2035)” Schwegman, Lundberg & Woessner, P.A.
22
Sep
SDNY: Use of Photojournalists’ 9/11 Footage May Be Fair Use Finnegan
22
Sep
Predictably Part 2: Merck Overcomes Obviousness Challenge at the PTAB Finnegan
22
Sep
Episode 40: A Deep Dive Into the Trade Secret Misappropriation Statute of Limitations [PODCAST] Greenberg Traurig, LLP
22
Sep
Federal Circuit Denies Mandamus Petition, Confirming Non-Appealability of Institution Decisions Despite Parties’ Agreement to First Arbitrate Patent Validity Finnegan
21
Sep
When It Isn’t Better Late Than Never: ALJ Reins in on Redesigns First Disclosed in the Last Week of Fact Discovery Mintz
21
Sep
NFT License Breakdown: Exploring Different Marketplaces and Associated License Issues Sheppard, Mullin, Richter & Hampton LLP
21
Sep
N.D. Ill. Finds that a Foreign Parent Corp. May be Sued Under BPCIA Without the U.S. Subsidiary that Signed and Filed aBLA Mintz
21
Sep
Predictably, a Funny Thing Happened on the Way to the PTAB FWD - Part 1: Merck Overcomes Inherent Anticipation Challenge at the PTAB Finnegan

Pages

Advertisement
Advertisement